aluates Reports

$ 0.0

Automative

Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-39C13440

Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Research Report 2023

BUY CHAPTERS

Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Research Report 2025

Code: QYRE-Auto-39C13440

Report

June 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott Laboratories Inc

B Braun Melsungen AG

Bayer

Boston Scientific Corporation

Cardiovascular Systems Inc.

Cook Group

C R Bard Inc

Edwards Lifesciences

Getinge Group

iVascular

Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.)

Kyoto Medical Planning Corporation Ltd.

Lepu Medical Technology

Medtronic Inc

Interventional Cardiology Diagnostic and Therapeutic Devices Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Interventional Cardiology Diagnostic and Therapeutic Devices Market

The global market for Interventional Cardiology Diagnostic and Therapeutic Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Interventional Cardiology Diagnostic and Therapeutic Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Cardiology Diagnostic and Therapeutic Devices.

The Interventional Cardiology Diagnostic and Therapeutic Devices market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Interventional Cardiology Diagnostic and Therapeutic Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Interventional Cardiology Diagnostic and Therapeutic Devices companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Interventional Cardiology Diagnostic and Therapeutic Devices Market Report

Report Metric	Details
Report Name	Interventional Cardiology Diagnostic and Therapeutic Devices Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Diagnostic Devices Therapeutic Devices Coronary Atherectomy Systems
Segment by Application	Hospitals Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Inc., B. Braun Melsungen AG, Bayer AG, Boston Scientific Corporation, Cardiovascular Systems Inc., Cook Group, C.R. Bard, Inc., Edwards Lifesciences, Getinge Group, iVascular, Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.), Kyoto Medical Planning Corporation Ltd., Lepu Medical Technology, Medtronic, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Cardiology Diagnostic and Therapeutic Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Interventional Cardiology Diagnostic and Therapeutic Devices Market report?

Ans: The main players in the Interventional Cardiology Diagnostic and Therapeutic Devices Market are Abbott Laboratories, Inc., B. Braun Melsungen AG, Bayer AG, Boston Scientific Corporation, Cardiovascular Systems Inc., Cook Group, C.R. Bard, Inc., Edwards Lifesciences, Getinge Group, iVascular, Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.), Kyoto Medical Planning Corporation Ltd., Lepu Medical Technology, Medtronic, Inc.

What are the Application segmentation covered in the Interventional Cardiology Diagnostic and Therapeutic Devices Market report?

Ans: The Applications covered in the Interventional Cardiology Diagnostic and Therapeutic Devices Market report are Hospitals, Clinics

What are the Type segmentation covered in the Interventional Cardiology Diagnostic and Therapeutic Devices Market report?

Ans: The Types covered in the Interventional Cardiology Diagnostic and Therapeutic Devices Market report are Diagnostic Devices, Therapeutic Devices, Coronary Atherectomy Systems

Recommended Reports

Cardiac Imaging Devices

Cardiology Intervention Devices

Therapeutic Cardiology Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Diagnostic Devices

1.2.3 Therapeutic Devices

1.2.4 Coronary Atherectomy Systems

1.3 Market by Application

1.3.1 Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Perspective (2020-2031)

2.2 Global Interventional Cardiology Diagnostic and Therapeutic Devices Growth Trends by Region

2.2.1 Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Interventional Cardiology Diagnostic and Therapeutic Devices Historic Market Size by Region (2020-2025)

2.2.3 Interventional Cardiology Diagnostic and Therapeutic Devices Forecasted Market Size by Region (2026-2031)

2.3 Interventional Cardiology Diagnostic and Therapeutic Devices Market Dynamics

2.3.1 Interventional Cardiology Diagnostic and Therapeutic Devices Industry Trends

2.3.2 Interventional Cardiology Diagnostic and Therapeutic Devices Market Drivers

2.3.3 Interventional Cardiology Diagnostic and Therapeutic Devices Market Challenges

2.3.4 Interventional Cardiology Diagnostic and Therapeutic Devices Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Interventional Cardiology Diagnostic and Therapeutic Devices Players by Revenue

3.1.1 Global Top Interventional Cardiology Diagnostic and Therapeutic Devices Players by Revenue (2020-2025)

3.1.2 Global Interventional Cardiology Diagnostic and Therapeutic Devices Revenue Market Share by Players (2020-2025)

3.2 Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Interventional Cardiology Diagnostic and Therapeutic Devices Revenue

3.4 Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Concentration Ratio

3.4.1 Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Interventional Cardiology Diagnostic and Therapeutic Devices Revenue in 2024

3.5 Global Key Players of Interventional Cardiology Diagnostic and Therapeutic Devices Head office and Area Served

3.6 Global Key Players of Interventional Cardiology Diagnostic and Therapeutic Devices, Product and Application

3.7 Global Key Players of Interventional Cardiology Diagnostic and Therapeutic Devices, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Interventional Cardiology Diagnostic and Therapeutic Devices Breakdown Data by Type

4.1 Global Interventional Cardiology Diagnostic and Therapeutic Devices Historic Market Size by Type (2020-2025)

4.2 Global Interventional Cardiology Diagnostic and Therapeutic Devices Forecasted Market Size by Type (2026-2031)

5 Interventional Cardiology Diagnostic and Therapeutic Devices Breakdown Data by Application

5.1 Global Interventional Cardiology Diagnostic and Therapeutic Devices Historic Market Size by Application (2020-2025)

5.2 Global Interventional Cardiology Diagnostic and Therapeutic Devices Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size (2020-2031)

6.2 North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2020-2025)

6.4 North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Size (2020-2031)

7.2 Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2020-2025)

7.4 Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Size (2020-2031)

8.2 Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Region (2020-2025)

8.4 Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size (2020-2031)

9.2 Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2020-2025)

9.4 Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Size (2020-2031)

10.2 Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2020-2025)

10.4 Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories, Inc.

11.1.1 Abbott Laboratories, Inc. Company Details

11.1.2 Abbott Laboratories, Inc. Business Overview

11.1.3 Abbott Laboratories, Inc. Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.1.4 Abbott Laboratories, Inc. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.1.5 Abbott Laboratories, Inc. Recent Development

11.2 B. Braun Melsungen AG

11.2.1 B. Braun Melsungen AG Company Details

11.2.2 B. Braun Melsungen AG Business Overview

11.2.3 B. Braun Melsungen AG Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.2.4 B. Braun Melsungen AG Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.2.5 B. Braun Melsungen AG Recent Development

11.3 Bayer AG

11.3.1 Bayer AG Company Details

11.3.2 Bayer AG Business Overview

11.3.3 Bayer AG Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.3.4 Bayer AG Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.3.5 Bayer AG Recent Development

11.4 Boston Scientific Corporation

11.4.1 Boston Scientific Corporation Company Details

11.4.2 Boston Scientific Corporation Business Overview

11.4.3 Boston Scientific Corporation Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.4.4 Boston Scientific Corporation Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.4.5 Boston Scientific Corporation Recent Development

11.5 Cardiovascular Systems Inc.

11.5.1 Cardiovascular Systems Inc. Company Details

11.5.2 Cardiovascular Systems Inc. Business Overview

11.5.3 Cardiovascular Systems Inc. Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.5.4 Cardiovascular Systems Inc. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.5.5 Cardiovascular Systems Inc. Recent Development

11.6 Cook Group

11.6.1 Cook Group Company Details

11.6.2 Cook Group Business Overview

11.6.3 Cook Group Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.6.4 Cook Group Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.6.5 Cook Group Recent Development

11.7 C.R. Bard, Inc.

11.7.1 C.R. Bard, Inc. Company Details

11.7.2 C.R. Bard, Inc. Business Overview

11.7.3 C.R. Bard, Inc. Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.7.4 C.R. Bard, Inc. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.7.5 C.R. Bard, Inc. Recent Development

11.8 Edwards Lifesciences

11.8.1 Edwards Lifesciences Company Details

11.8.2 Edwards Lifesciences Business Overview

11.8.3 Edwards Lifesciences Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.8.4 Edwards Lifesciences Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.8.5 Edwards Lifesciences Recent Development

11.9 Getinge Group

11.9.1 Getinge Group Company Details

11.9.2 Getinge Group Business Overview

11.9.3 Getinge Group Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.9.4 Getinge Group Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.9.5 Getinge Group Recent Development

11.10 iVascular

11.10.1 iVascular Company Details

11.10.2 iVascular Business Overview

11.10.3 iVascular Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.10.4 iVascular Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.10.5 iVascular Recent Development

11.11 Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.)

11.11.1 Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Company Details

11.11.2 Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Business Overview

11.11.3 Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.11.4 Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.11.5 Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Recent Development

11.12 Kyoto Medical Planning Corporation Ltd.

11.12.1 Kyoto Medical Planning Corporation Ltd. Company Details

11.12.2 Kyoto Medical Planning Corporation Ltd. Business Overview

11.12.3 Kyoto Medical Planning Corporation Ltd. Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.12.4 Kyoto Medical Planning Corporation Ltd. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.12.5 Kyoto Medical Planning Corporation Ltd. Recent Development

11.13 Lepu Medical Technology

11.13.1 Lepu Medical Technology Company Details

11.13.2 Lepu Medical Technology Business Overview

11.13.3 Lepu Medical Technology Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.13.4 Lepu Medical Technology Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.13.5 Lepu Medical Technology Recent Development

11.14 Medtronic, Inc.

11.14.1 Medtronic, Inc. Company Details

11.14.2 Medtronic, Inc. Business Overview

11.14.3 Medtronic, Inc. Interventional Cardiology Diagnostic and Therapeutic Devices Introduction

11.14.4 Medtronic, Inc. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

11.14.5 Medtronic, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories Inc

B Braun Melsungen AG

Bayer

Boston Scientific Corporation

Cardiovascular Systems Inc.

Cook Group

C R Bard Inc

Edwards Lifesciences

Getinge Group

iVascular

Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.)

Kyoto Medical Planning Corporation Ltd.

Lepu Medical Technology

Medtronic Inc

List of Tables

Table 1. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Diagnostic Devices

Table 3. Key Players of Therapeutic Devices

Table 4. Key Players of Coronary Atherectomy Systems

Table 5. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Region (2020-2025)

Table 9. Global Interventional Cardiology Diagnostic and Therapeutic Devices Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Region (2026-2031)

Table 11. Interventional Cardiology Diagnostic and Therapeutic Devices Market Trends

Table 12. Interventional Cardiology Diagnostic and Therapeutic Devices Market Drivers

Table 13. Interventional Cardiology Diagnostic and Therapeutic Devices Market Challenges

Table 14. Interventional Cardiology Diagnostic and Therapeutic Devices Market Restraints

Table 15. Global Interventional Cardiology Diagnostic and Therapeutic Devices Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Players (2020-2025)

Table 17. Global Top Interventional Cardiology Diagnostic and Therapeutic Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices as of 2024)

Table 18. Ranking of Global Top Interventional Cardiology Diagnostic and Therapeutic Devices Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Interventional Cardiology Diagnostic and Therapeutic Devices Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Interventional Cardiology Diagnostic and Therapeutic Devices, Headquarters and Area Served

Table 21. Global Key Players of Interventional Cardiology Diagnostic and Therapeutic Devices, Product and Application

Table 22. Global Key Players of Interventional Cardiology Diagnostic and Therapeutic Devices, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Interventional Cardiology Diagnostic and Therapeutic Devices Revenue Market Share by Type (2020-2025)

Table 26. Global Interventional Cardiology Diagnostic and Therapeutic Devices Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Interventional Cardiology Diagnostic and Therapeutic Devices Revenue Market Share by Type (2026-2031)

Table 28. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Interventional Cardiology Diagnostic and Therapeutic Devices Revenue Market Share by Application (2020-2025)

Table 30. Global Interventional Cardiology Diagnostic and Therapeutic Devices Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Interventional Cardiology Diagnostic and Therapeutic Devices Revenue Market Share by Application (2026-2031)

Table 32. North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Country (2026-2031) & (US$ Million)

Table 47. Abbott Laboratories, Inc. Company Details

Table 48. Abbott Laboratories, Inc. Business Overview

Table 49. Abbott Laboratories, Inc. Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 50. Abbott Laboratories, Inc. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 51. Abbott Laboratories, Inc. Recent Development

Table 52. B. Braun Melsungen AG Company Details

Table 53. B. Braun Melsungen AG Business Overview

Table 54. B. Braun Melsungen AG Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 55. B. Braun Melsungen AG Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 56. B. Braun Melsungen AG Recent Development

Table 57. Bayer AG Company Details

Table 58. Bayer AG Business Overview

Table 59. Bayer AG Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 60. Bayer AG Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 61. Bayer AG Recent Development

Table 62. Boston Scientific Corporation Company Details

Table 63. Boston Scientific Corporation Business Overview

Table 64. Boston Scientific Corporation Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 65. Boston Scientific Corporation Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 66. Boston Scientific Corporation Recent Development

Table 67. Cardiovascular Systems Inc. Company Details

Table 68. Cardiovascular Systems Inc. Business Overview

Table 69. Cardiovascular Systems Inc. Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 70. Cardiovascular Systems Inc. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 71. Cardiovascular Systems Inc. Recent Development

Table 72. Cook Group Company Details

Table 73. Cook Group Business Overview

Table 74. Cook Group Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 75. Cook Group Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 76. Cook Group Recent Development

Table 77. C.R. Bard, Inc. Company Details

Table 78. C.R. Bard, Inc. Business Overview

Table 79. C.R. Bard, Inc. Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 80. C.R. Bard, Inc. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 81. C.R. Bard, Inc. Recent Development

Table 82. Edwards Lifesciences Company Details

Table 83. Edwards Lifesciences Business Overview

Table 84. Edwards Lifesciences Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 85. Edwards Lifesciences Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 86. Edwards Lifesciences Recent Development

Table 87. Getinge Group Company Details

Table 88. Getinge Group Business Overview

Table 89. Getinge Group Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 90. Getinge Group Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 91. Getinge Group Recent Development

Table 92. iVascular Company Details

Table 93. iVascular Business Overview

Table 94. iVascular Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 95. iVascular Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 96. iVascular Recent Development

Table 97. Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Company Details

Table 98. Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Business Overview

Table 99. Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 100. Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 101. Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Recent Development

Table 102. Kyoto Medical Planning Corporation Ltd. Company Details

Table 103. Kyoto Medical Planning Corporation Ltd. Business Overview

Table 104. Kyoto Medical Planning Corporation Ltd. Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 105. Kyoto Medical Planning Corporation Ltd. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 106. Kyoto Medical Planning Corporation Ltd. Recent Development

Table 107. Lepu Medical Technology Company Details

Table 108. Lepu Medical Technology Business Overview

Table 109. Lepu Medical Technology Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 110. Lepu Medical Technology Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 111. Lepu Medical Technology Recent Development

Table 112. Medtronic, Inc. Company Details

Table 113. Medtronic, Inc. Business Overview

Table 114. Medtronic, Inc. Interventional Cardiology Diagnostic and Therapeutic Devices Product

Table 115. Medtronic, Inc. Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025) & (US$ Million)

Table 116. Medtronic, Inc. Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Interventional Cardiology Diagnostic and Therapeutic Devices Picture

Figure 2. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Type: 2024 VS 2031

Figure 4. Diagnostic Devices Features

Figure 5. Therapeutic Devices Features

Figure 6. Coronary Atherectomy Systems Features

Figure 7. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Interventional Cardiology Diagnostic and Therapeutic Devices Report Years Considered

Figure 12. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Region: 2024 VS 2031

Figure 15. Global Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Players in 2024

Figure 16. Global Top Interventional Cardiology Diagnostic and Therapeutic Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Cardiology Diagnostic and Therapeutic Devices as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Interventional Cardiology Diagnostic and Therapeutic Devices Revenue in 2024

Figure 18. North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Country (2020-2031)

Figure 20. United States Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Country (2020-2031)

Figure 24. Germany Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Region (2020-2031)

Figure 32. China Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Country (2020-2031)

Figure 40. Mexico Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Interventional Cardiology Diagnostic and Therapeutic Devices Market Share by Country (2020-2031)

Figure 44. Turkey Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Interventional Cardiology Diagnostic and Therapeutic Devices Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Abbott Laboratories, Inc. Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 48. B. Braun Melsungen AG Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 49. Bayer AG Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 50. Boston Scientific Corporation Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 51. Cardiovascular Systems Inc. Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 52. Cook Group Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 53. C.R. Bard, Inc. Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 54. Edwards Lifesciences Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 55. Getinge Group Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 56. iVascular Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 57. Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.) Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 58. Kyoto Medical Planning Corporation Ltd. Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 59. Lepu Medical Technology Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 60. Medtronic, Inc. Revenue Growth Rate in Interventional Cardiology Diagnostic and Therapeutic Devices Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User